Biostax Corp. (BTAX)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Sep 29, 2026, 4:00 PM EST
Biostax Market Cap
Biostax has a market cap or net worth of $21.65 thousand as of September 30, 2026. Its market cap has increased by 150.78% in one year.
Market Cap
21.65K
Enterprise Value
1.18M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since May 14, 2012, Biostax's market cap has decreased from 377.40K to 21.65K, a decrease of -94.26%. That is a compound annual growth rate of -18.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2026 | 21.65K | -98.38% |
| Dec 31, 2024 | 1.34M | -78.10% |
| Dec 28, 2023 | 6.11M | -87.74% |
| Dec 30, 2022 | 49.83M | 3,358.09% |
| Dec 30, 2021 | 1.44M | -78.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Itoco | 42.82K |
| Nascent Biotech | 34.57K |
| Carisma Therapeutics | 29.29K |
| Entia Biosciences | 27.25K |
| Bio-Path Holdings | 25.15K |
| Health Sciences Group | 20.51K |
| Scopus BioPharma | 16.83K |
| Windtree Therapeutics | 13.50K |